In Vitro Activity of Eravacycline, Aztreonam–Avibactam, and Cefiderocol Against Multidrug-Resistant Gram-Negative Clinical Isolates from a Romanian Tertiary Hospital
Background/Objectives: Carbapenem-resistant Gram-negative bacteria—especially NDM- and OXA-48-producing Klebsiella pneumoniae and carbapenem-resistant Acinetobacter baumannii (CRAB)—have limited treatment options, and in vitro data from Eastern Europe on the reserve agents eravacycline, aztreonam–avibactam, and cefider...